Illumina, Inc. (ILMN)
Illumina faces scrutiny over a significant loss on its Omniome acquisition, selling the short-read sequencing assets for a fraction of the purchase price. This comes amidst broader market downturns and negative sentiment surrounding the stock.
About Illumina, Inc.
Illumina, Inc. is a company focused on DNA sequencing and genomics.
Illumina, Inc. uses the ticker $ILMN for trading. Listed in the Stocks category within the Healthcare sectors.
Insights
- Illumina, Inc. (ILMN) sentiment is up 21.95% from the previous week.
Price: $116.80
Price 24-Hour Time-Series Raw Data
Despite reaching a 52-week high, Illumina's stock is experiencing short-term declines due to prevailing negative sentiment and broader market downturns, as evidenced by social posts discussing its performance and Cathie Wood's recent sale of the stock.
24-Hour: 1.4% 7-Day: -2.32% 30-Day: -17.54%
1-Year High: $154 on 2026-01-22
1-Year Low: $70.30 on 2025-04-08
AltRank: [-----]
AltRank 24-Hour Time-Series Raw Data
Illumina, Inc. (ILMN) is currently AltRank #1,319 based on combined combined social and market metrics
Daily Average: [---]
[--] Week: [---] +166
[--] Month: [---] +279
[--] Months: [---] +307
[--] Year: [---] +720
1-Year High: [-----] on 2026-02-15
1-Year Low: [--] on 2025-07-06
Galaxy Score: [-----]
Galaxy Score 24-Hour Time-Series Raw Data
Current Value: [-----]
Daily Average: [--]
[--] Week: [--] [---]
[--] Month: [--] +17
[--] Months: [--] [---]
[--] Year: [--] [---]
1-Year High: [--] on 2025-07-26
1-Year Low: [--] on 2025-09-10
Engagements: [-----] (24h)
Engagements 24-Hour Time-Series Raw Data
Current Value: [-----]
Daily Average: [------]
[--] Week: [------] -82%
[--] Month: [-------] +192%
[--] Months: [---------] -44%
[--] Year: [---------] -26%
1-Year High: [-------] on 2025-03-04
1-Year Low: [---] on 2026-01-04
Engagements by network (24h): Reddit: [--] X: [-----] YouTube: [--] News: [--]
Mentions: [---] (24h)
Mentions 24-Hour Time-Series Raw Data
Current Value: [---]
Daily Average: [---]
[--] Week: [---] -17%
[--] Month: [-----] +66%
[--] Months: [-----] -64%
[--] Year: [------] +60%
1-Year High: [-----] on 2025-07-03
1-Year Low: [--] on 2025-12-14
Mentions by network (24h): Reddit: [--] X: [---] YouTube: [--] News: [--]
Creators: [--] (24h)
Creators 24-Hour Time-Series Raw Data
[--] unique social accounts have posts mentioning Illumina, Inc. (ILMN) in the last [--] hours which is down 35% from [---] in the previous [--] hours
Daily Average: [---]
[--] Week: [---] -29%
[--] Month: [---] +109%
[--] Months: [-----] -75%
[--] Year: [------] +247%
1-Year High: [-----] on 2025-07-03
1-Year Low: [--] on 2025-12-14
The most influential creators that mention Illumina, Inc. in the last [--] hours
| Creator | Rank | Followers | Posts | Engagements |
|---|---|---|---|---|
| @TohJah7809 | [--] | [-----] | [--] | [-----] |
| @LifeSciLad | [--] | [---] | [--] | [---] |
| @Dykegail | [--] | [--] | [--] | [---] |
| @Tickeron | [--] | [------] | [--] | [--] |
| @OptionSkull | [--] | [---] | [--] | [--] |
| @tricktrades1 | [--] | [-----] | [--] | [--] |
| @AIStockSavvy | [--] | [------] | [--] | [--] |
| @nanalyzetweets | [--] | [-----] | [--] | [--] |
| @ArkFund_Tracker | [--] | [---] | [--] | [--] |
| @Carl_C_Icahn | [--] | [-------] | [--] | [--] |
Sentiment: 78%
Sentiment 24-Hour Time-Series Raw Data
Current Value: 78%
Daily Average: 67%
[--] Week: 100% +18%
[--] Month: 76% -4%
[--] Months: 76% +2%
[--] Year: 76% +21%
1-Year High: 100% on 2025-07-03
1-Year Low: 25% on 2025-03-15
Most Supportive Themes:
- Undervalued Stock: (25%) Posts highlight Illumina as an undervalued stock with insider buying, suggesting potential for future growth.
- Genomics and AI Innovation: (20%) Mentions of Illumina in the context of genomics, AI, and the potential for innovation and growth in the field.
Most Critical Themes:
- Market Downturn Impact: (35%) Many posts mention Illumina as a loser in the current market downturn, indicating negative price action.
- Regulatory and Competitive Challenges: (15%) Mentions of regulatory and competitive challenges facing Illumina, which could be impacting its performance.
Social Dominance: 0.00834%
Social Dominance 24-Hour Time-Series Raw Data
Current Value: 0.00834%
Daily Average: 0.032%
[--] Week: 0.00887% -0.00493%
[--] Month: 0.017% -0.0043%
[--] Months: 0.017% -0.0068%
[--] Year: 0.017% -0.033%
1-Year High: 0.216% on 2025-07-03
1-Year Low: 0.0047% on 2025-12-14
Market Dominance: 0.02%
Market Dominance 24-Hour Time-Series Raw Data
Current Value: 0.02%
Daily Average: 0%
1-Year High: 0.027% on 2026-01-21
1-Year Low: 0.017% on 2025-05-06
Market Cap: $17,848,568,000
Market Cap 24-Hour Time-Series Raw Data
Current Value: $17,848,568,000
Daily Average: $16,014,875,021
[--] Week: $17,770,258,000 -1.70%
[--] Month: $17,860,249,000 -17%
[--] Months: $17,860,249,000 +12%
[--] Year: $17,860,249,000 +13%
1-Year High: $23,523,560,000 on 2026-01-22
1-Year Low: $11,128,490,000 on 2025-04-08
Top Illumina, Inc. Social Posts
Top posts by engagements in the last [--] hours
Showing a maximum of [--] top social posts without a LunarCrush subscription.
"So $PACB bought Omniome for $760m ($600m upfront + $160m commercial milestone in cash + shares) Then sold to $ILMN for $48m -94% writedown in 5Y. what a disaster ❗🤮 Adjacent market (short read) doesn't mean it can be your core competency 🤦♂ https://x.com/TohJah7809/status/1706637497466487259s=20 $PACB PacBio Completes Sale of Short-Read Sequencing Assets to Illumina $ILMN 🤦♂ Disastrous foray into short-read sequencing: Omniome acquisition in [----] Onso short-read sequencer launched in [----] 🥼🔬🧫🧪🦠🧬💻🧑🔬🤒🌡💉🩸🩹💊😷🩺🏥⚕ https://t.co/YnpmD8VcLe"
X Link @TohJah7809 2026-02-15T15:37Z [----] followers, [---] engagements
"$PACB Omniome short-read acquisition https://x.com/LifeSciLad/status/2018410167487049856s=20 $PACB bought Omniome for the short-read sequencing technology for a potential total of $800M in [----] only to end up selling it to $ILMN last week for $48.1M. https://t.co/Oir5N9ZCM3 https://x.com/LifeSciLad/status/2018410167487049856s=20 $PACB bought Omniome for the short-read sequencing technology for a potential total of $800M in [----] only to end up selling it to $ILMN last week for $48.1M. https://t.co/Oir5N9ZCM3"
X Link @TohJah7809 2026-02-15T15:09Z [----] followers, [---] engagements
"$PACB PacBio Completes Sale of Short-Read Sequencing Assets to Illumina $ILMN 🤦♂ Disastrous foray into short-read sequencing: Omniome acquisition in [----] Onso short-read sequencer launched in [----] 🥼🔬🧫🧪🦠🧬💻🧑🔬🤒🌡💉🩸🩹💊😷🩺🏥⚕"
X Link @TohJah7809 2026-02-15T15:02Z [----] followers, [---] engagements
"$PACB bought Omniome for the short-read sequencing technology for a potential total of $800M in [----] only to end up selling it to $ILMN last week for $48.1M. https://investor.pacificbiosciences.com/news-releases/news-release-details/pacbio-completes-sale-short-read-sequencing-assets https://investor.pacificbiosciences.com/news-releases/news-release-details/pacbio-completes-sale-short-read-sequencing-assets"
X Link @LifeSciLad 2026-02-02T19:44Z [---] followers, [----] engagements
Limited data mode. Full metrics available with subscription: lunarcrush.com/pricing